Search

Translocation (14;18)(q32;q21) has been shown to be present in diagnostic tissue specimens from approximately 85% of patients with follicular lymphoma (FL) and 30% with diffuse non-Hodgkin lymphomas (NHL) in the USA. Also, there is evidence that the distribution of NHL subtypes differs by geographic region; however, there are no data for Ecuador. Using polymerase chain reaction, we examined the frequency of t(14;18) (MBR and mcr rearrangements) in 65 NHL samples collected through 5 years from the principal hospitals of Quito, Ecuador. Of 65 NHL, only 5 were FL, which represents an incidence of 7.7%. This incidence is lower than observed in North America (30%). In addition, we did not find the t(14;18) in the samples analyzed, absence of which was confirmed by the use of a control. This suggests that this translocation is rare in NHL in Ecuador. These findings confirm that there are differences in the incidence of specific subtypes of NHL across some geographic areas and suggest that genetic factors may be responsible for the observed differences.

Translocation (14;18)(q32;q21) has been shown to be present in diagnostic tissue specimens from approximately 85% of patients with follicular lymphoma (FL) and 30% with diffuse non-Hodgkin lymphomas (NHL) in the USA. Also, there is evidence that the distribution of NHL subtypes differs by geographic region; however, there are no data for Ecuador. Using polymerase chain reaction, we examined the frequency of t(14;18) (MBR and mcr rearrangements) in 65 NHL samples collected through 5 years from the principal hospitals of Quito, Ecuador. Of 65 NHL, only 5 were FL, which represents an incidence of 7.7%. This incidence is lower than observed in North America (30%). In addition, we did not find the t(14;18) in the samples analyzed, absence of which was confirmed by the use of a control. This suggests that this translocation is rare in NHL in Ecuador. These findings confirm that there are differences in the incidence of specific subtypes of NHL across some geographic areas and suggest that genetic factors may be responsible for the observed differences.

Different BCR-ABL transcript variants occur more or less frequently, according to the leukemia type. We report the frequencies of BCR-ABL transcript variants studied in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) patients in the Ecuadorian population. The frequencies found for CML patients in this study were 94.6% for the b2/a2 rearrangement and 5.4% for the b3/a2 rearrangement; whereas in ALL, all cases (100%) that presented the BCR-ABL rearrangement had the e1/a2 junction. Since our results differ from the frequencies previously reported, we suggest that this may be due to a different genetic background in the population involved in this study when compared to the populations analyzed in prior studies. Furthermore, we recommend a survey of the BCR-ABL transcript variants and their frequencies in different ethnic groups.

This study compares the frequency of telomeric associations in the peripheral blood of women suffering breast and cervix uterine cancer with a healthy control group. Two kinds of cultures were developed for each individual: with and without aphidicolin. In the normal cultures, the number of telomeric associations observed was 95.5 times higher in individuals affected by breast cancer and 41.3 times higher in those affected by cervix uterine cancer when compared to the control group (p < 0.001). In the cultures with aphidicolin, higher numbers of altered metaphases were observed in both groups as compared to the control groups (p < 0.001). Statistically significant differences (p < 0.001) could also be observed when comparing telomeric associations between the two types of cancer in both cultures. When we compared individuals affected by breast cancer in both types of cultures statistical differences were found (p < 0.05), and similar results were found in individuals affected by uterine cervix cancer (p < 0.001). The findings suggest that telomeric associations may be reflecting chromosome instability observed in cancer and that this instability behaves differently for various types of cancer.